106 studies found for:    interstitial lung disease AND children
Show Display Options
Rank Status Study
21 Active, not recruiting Phenotyping the Chronic Respiratory Diseases (CRD) in Ho Chi Minh City, Vietnam
Condition: Chronic Respiratory Diseases
Intervention: Other: epidemiology
22 Completed Panitumumab for Intravenous Infusion 100 mg and 400 mg Special Drug Use Surveillance "Survey on Unresectable, Advanced or Recurrent Colorectal Cancer With Wild-type KRAS Gene" (All-patient Surveillance)
Condition: Advanced or Recurrent Colorectal Cancer
Intervention: Drug: Panitumumab
23 Completed Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Biological DMARDs;   Drug: Non-Biologic DMARDs
24 Recruiting Tagrisso Tablets Clinical Experience Investigation (All Case Investigation)
Condition: All Patients Treated With the Product
Intervention:
25 Terminated Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)
Conditions: Bronchopulmonary Dysplasia;   Respiratory Distress Syndrome;   Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature
Interventions: Procedure: Minimal mechanical ventilation management;   Procedure: Routine mechanical ventilation management;   Drug: Dexamethasone;   Drug: Placebo
26 Completed Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
Conditions: Lung Diseases;   Pulmonary Fibrosis;   Lung Diseases, Interstitial;   Scleroderma, Systemic
Intervention:
27 Completed Idiopathic Pulmonary Fibrosis: a Case-control Study
Conditions: Lung Diseases;   Pulmonary Fibrosis;   Lung Diseases, Interstitial
Intervention:
28 Completed Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists
Conditions: Hospitalized Cases of Angioneurotic Oedema;   Pneumonia;   Gastroenteritis;   Failure to Thrive;   Seizures;   Acute Interstitial Nephritis and Thrombocytopenia
Intervention:
29 Unknown  Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications
Conditions: Lung Neoplasm;   Lung Diseases, Interstitial;   Respiratory Tract Infections;   Pleural Effusions
Intervention: Procedure: Respiratory endoscopy
30 Completed The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms
Condition: HIV Infections
Intervention: Drug: Zidovudine
31 Completed Lung Diffusing Capacity for Nitric Oxide as a Marker of Fibrotic Changes in Idiopathic Interstitial Pneumonias
Conditions: Usual Interstitial Pneumonia;   Nonspecific Interstitial Pneumonia
Intervention:
32 Terminated DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)
Conditions: Pneumonia, Interstitial Plasma Cell;   Pneumocystis Carinii Pneumonia;   Pneumonia, Pneumocystis Carinii;   HIV Infections
Interventions: Drug: Pafuramidine maleate (DB289);   Drug: Trimethoprim-Sulfamethoxazole (TMP-SMX)
33 Completed Herpesvirus in Idiopathic Pulmonary Fibrosis
Conditions: Lung Diseases;   Herpesvirus Infections
Intervention:
34 Recruiting A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
Condition: Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
Intervention: Drug: Prograf
35 Recruiting Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   Familial Pulmonary Fibrosis;   Idiopathic Interstitial Pneumonia;   Familial Interstitial Pneumonia
Intervention:
36 Unknown  Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
Conditions: Interstitial Pneumonitis;   Polymyositis;   Dermatomyositis
Intervention: Drug: Tacrolimus
37 Terminated An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Fibrosis;   Lung Disease
Intervention: Drug: Interferon gamma-1b
38 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
39 Completed Specialized Center of Research in Occupational and Immunologic Lung Disease
Conditions: Lung Diseases, Obstructive;   Asbestosis;   Silicosis;   Pneumoconiosis;   Chronic Obstructive Pulmonary Disease
Intervention:
40 Recruiting Nandrolone Decanoate in the Treatment of Telomeropathies
Conditions: Aplastic Anemia;   Bone Marrow Failure Syndromes;   Idiopathic Pulmonary Fibrosis;   Telomere Shortening
Intervention: Drug: Nandrolone Decanoate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years